A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors

Phase 1 trial finds triple monoclonal antibody combination safe and effective for HIV-1 prevention

This phase 1, multicentre, randomised, open-label trial (HVTN 140/HPTN 101 part B) evaluated the safety, pharmacokinetics, and neutralisatio

Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

Avacta Therapeutics presents platform-validating data for faridoxorubicin in salivary gland cancer at BIO International Conference

Avacta Therapeutics announced platform-validating clinical data for faridoxorubicin (AVA6000), a tumor-activated oncology drug using its pre

Salmonella-based delivery system enables oncolytic parvovirus to shrink solid tumors and generate antitumor immune memory

Researchers have engineered a Salmonella vector that delivers the H-1 parvovirus directly into solid tumors, overcoming the key limitation o